Grace Therapeutics, Inc. Interest Receivable, Current
Grace Therapeutics, Inc. (GRCE) had Interest Receivable, Current of $0 as of 2025-03-31, per its 10-K filed 2025-06-23.
Financial Statements › Notes › Nontrade Receivables
us-gaap:InterestReceivableCurrent · last filed 2025-06-23
- 2025-03-31: Interest Receivable, Current $0.00.
- 2024-12-31: Interest Receivable, Current $0.00.
- 2024-09-30: Interest Receivable, Current $0.00.
- 2024-06-30: Interest Receivable, Current $5.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2025-03-31 | $0.00 10-K · filed 2025-06-23 |
| 2024-12-31 | $0.00 10-Q · filed 2025-02-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-13 |
| 2024-06-30 | $5.00K 10-Q · filed 2024-08-09 |
| 2024-03-31 | $15.00K 10-K · filed 2025-06-23 |
| 2023-12-31 | $164.00K 10-Q · filed 2024-02-12 |
| 2023-09-30 | $94.00K 10-Q · filed 2023-11-13 |
| 2023-06-30 | $50.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $52.00K 10-K · filed 2024-06-21 |
| 2022-03-31 | $11.00K 10-K · filed 2023-06-23 |
| 2021-03-31 | $13.00K 10-K · filed 2022-06-21 |
| 2020-03-31 | $11.00K 10-K · filed 2021-06-22 |
| 2019-03-31 | $69.00K 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |